Glutamate-based Therapies for Psychiatric Disorders

Both metabotropic and ionotropic glutamate receptors present attractive "druggable" targets in treating disorders of the central nervous system. There has been a dramatic shift in the focus of glutamate-based therapies away from neurologic disorders such as stroke and traumatic brain injur...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Skolnick, Phil (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Basel : Birkhäuser Basel : Imprint: Birkhäuser, 2010.
Edición:1st ed. 2010.
Colección:Milestones in Drug Therapy,
Temas:
Psychiatry.
Pharmacology.
Neurosciences.
Neuroscience.
Acceso en línea:Texto Completo

MARC

LEADER 00000nam a22000005i 4500
001 978-3-0346-0241-9
003 DE-He213
005 20220118074818.0
007 cr nn 008mamaa
008 100907s2010 sz | s |||| 0|eng d
020 |a 9783034602419  |9 978-3-0346-0241-9 
024 7 |a 10.1007/978-3-0346-0241-9  |2 doi 
050 4 |a RC434.2-574 
072 7 |a MMH  |2 bicssc 
072 7 |a MED105020  |2 bisacsh 
072 7 |a MKL  |2 thema 
082 0 4 |a 616.89  |2 23 
245 1 0 |a Glutamate-based Therapies for Psychiatric Disorders  |h [electronic resource] /  |c edited by Phil Skolnick. 
250 |a 1st ed. 2010. 
264 1 |a Basel :  |b Birkhäuser Basel :  |b Imprint: Birkhäuser,  |c 2010. 
300 |a XIV, 178 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Milestones in Drug Therapy,  |x 2296-6064 
505 0 |a N-Methyl-d-Aspartate (NMDA) Antagonists for the Treatment of Depression -- Ionic Glutamate Modulators in Depression (Zinc, Magnesium) -- Positive Allosteric Modulation of AMPA Receptors: A Novel Potential Antidepressant Therapy -- Glutamatergic Modulators for the Treatment of Major Depressive Disorder: Metabotropic Glutamate Receptors -- Positive Modulation of AMPA Receptors as a Broad-Spectrum Strategy for Treating Neuropsychiatric Disorders -- Activation of Group II Metabotropic Glutamate Receptors (mGluR2 and mGluR3) as a Novel Approach for Treatment of Schizophrenia -- mGluR1 Negative Allosteric Modulators: An Alternative Metabotropic Approach for the Treatment of Schizophrenia -- Metabotropic Glutamate Receptors as Targets for the Treatment of Drug and Alcohol Dependence -- Metabotropic Approaches to Anxiety. 
520 |a Both metabotropic and ionotropic glutamate receptors present attractive "druggable" targets in treating disorders of the central nervous system. There has been a dramatic shift in the focus of glutamate-based therapies away from neurologic disorders such as stroke and traumatic brain injury to the treatment of psychiatric disorders. This "Milestones in Drug Therapy" volume offers a unique, contemporary overview of preclinical and clinical evidence that modulating glutamatergic tone is an effective means of treating psychiatric disorders ranging from depression and anxiety to schizophrenia and drug abuse. The ability to treat diseases such as depression and schizophrenia through multiple, glutamate-based mechanisms offers a unique therapeutic opportunity, as described in this book. 
650 0 |a Psychiatry. 
650 0 |a Pharmacology. 
650 0 |a Neurosciences. 
650 1 4 |a Psychiatry. 
650 2 4 |a Pharmacology. 
650 2 4 |a Neuroscience. 
700 1 |a Skolnick, Phil.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9783034602402 
776 0 8 |i Printed edition:  |z 9783034602426 
830 0 |a Milestones in Drug Therapy,  |x 2296-6064 
856 4 0 |u https://doi.uam.elogim.com/10.1007/978-3-0346-0241-9  |z Texto Completo 
912 |a ZDB-2-SBL 
912 |a ZDB-2-SXB 
950 |a Biomedical and Life Sciences (SpringerNature-11642) 
950 |a Biomedical and Life Sciences (R0) (SpringerNature-43708) 

Ejemplares similares